Clinical trial
Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to…
NCT00226707 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00226707 |
|---|---|
| Title | Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis |
| Official title | A 6-Week Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy and Safety of Pimecrolimus Cream 1% in Patients With Mild-to-Moderate Chronic Hand Dermatitis Followed by a 6-Week Open-Label Phase to Assess the Safety of Pimecrolimus Cream 1% |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hand Dermatitis |
| Intervention type | Drug |
| Interventions | Pimecrolimus Cream 1% |
| Enrollment | 652 |
| Start date | Jul 1, 2004 |
| Completion | Mar 1, 2005 |
| First posted | Sep 27, 2005 |
| Last update posted | Feb 15, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: